Mortality in rheumatoid arthritis and ankylosing spondylitis

被引：0

作者：

Zochling, J. ^{[2
]}

Braun, J. ^{[1
]}

机构：

[1] St Josefs Hosp, Rheumazentrum Ruhrgebiet, D-44652 Herne, Germany

[2] Menzies Res Inst, Hobart, Tas, Australia

来源：

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2009年 / 27卷 / 04期

关键词：

Rheumatoid arthritis; ankylosing spondylins; mortality; population studies; MODIFYING ANTIRHEUMATIC DRUGS; ALCOHOL-RELATED DEATHS; CARDIOVASCULAR-DISEASE; RISK; METHOTREXATE; SURVIVAL;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The rheumatic diseases not only bring pain, disability and poorer quality of life, but also a permature mortality which is often overlooked. Alongside mortality due to the direct complications of disease comes an increase in deaths related to specific therapies and indirect causes such as cancer and cardiovascular mortality By comparing mortality and its causes in two of the most common inflammatory arthritides, rheumatoid arthritis and ankylosing spondylitis, common threads emerge which give us insight into the impact of chronic inflammatory disease and new directions for patient management.

引用

页码：S127 / S130

页数：4

共 37 条

[1] Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register [J].